Table 2.
Summary of 13 studies using hip-specific PROs in pediatric populations with impingement or impingement disorders
| Study | Number | PRO | Age at baseline (mean [range]) (years) | PRO preoperatively? | Time to followup (mean [range]) | PRO at followup? |
|---|---|---|---|---|---|---|
| Arora et al., 2013 [3] | 26 (30 hips) | Merle d’Aubigné Score | 3 (10–16) | No | 20 months (4–48 months) | Yes |
| Dean et al., 2001 [5] | 50 (54 hips) | Harris Hip Score | 15 (9–18) | Yes | 4 years (2–10 years) | Yes |
| Herman et al., 1996 [9] | 21 (21 hips) | Harris Hip Score | 14 (boys), 12 (girls) (no range) | No | 3 years (no range) | Yes |
| Kocher et al., 2005 [10] | 42 (48 hips) | Modified Harris Hip Score | 15 (6–18 y 11 m) | Yes | 17 months (12–26 months) | Yes |
| Kumar et al., 2002 [11] | 21 (22 hips) | Harris Hip Score | 8 (5–11) | Yes | 30 months (1–5 years) | Yes |
| Muratli et al., 2003 [14] | 14 (17 hips) | Iowa Hip Score | 7 (5–9) | No | Age at followup: 12 years (10–16 years) | Yes |
| Philippon et al., 2012 [15] | 60 (65 hips) | Modified Harris Hip Score | 15 (11–16) | Yes | 3 years (2–5 years) | Yes |
| Philippon et al., 2008 [16] | 16 (17 hips) | 1. Modified Harris Hip Score 2. Hip Outcome Score |
15 (11–16) | Yes | 16 months (1–2 years) | Yes |
| Schneidmueller et al., 2006 [18] | 44 (47 hips) | Merle d’Aubigné Score | 13 (6–17) | Yes | 8 years (1–17 years) | Yes |
| Sun et al., 2011 [21] | 11 (12 hips) | Harris Hip Score | 14 (9–18) | Yes | 6 years (2–12 years) | Yes |
| Tran et al., 2013 [23] | 34 (41 hips) | 1. Modified Harris Hip Score 2. Non-arthritic Hip Score |
16 (11–18) | Yes | 14 months (1–2 years) | Yes |
| Yoo et al., 2004 [25] | 21 (21 hips) | Iowa Hip Score | 10 (6–15) | Yes | 7 years (3–15 years) | Yes |
| Yoo et al., 2013 [26] | 31 (31 hips) | Iowa Hip Score | 9 (4–15) | Yes | 20 years (15–28 years) | Yes |
PROs = patient-reported outcomes.